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Short Summary 
A study on prenatal syphilis screening adherence found that majority of women with a stillbirth 
delivery do not receive syphilis testing in accordance with CDC-recommended screening 








Background: The Centers for Disease Control and Prevention (CDC) recommends that all 
women with a stillbirth have a syphilis test after delivery. Our study seeks to evaluate adherence 
to CDC guidelines for syphilis screening among women with a stillbirth delivery. 
Methods: We utilized data recorded in electronic health records for women who gave birth 
between January 1, 2014 and December 31, 2016. Patients were included if they were 18-44 
years old and possessed an ICD-9-CM or ICD-10-CM diagnosis of stillbirth. Stillbirth diagnoses 
were confirmed through a random sample of medical chart reviews. To evaluate syphilis 
screening, we estimated the proportion of women who received syphilis testing within 300 days 
before stillbirth, within 30 days after a stillbirth delivery, and women who received syphilis 
testing both before and after stillbirth delivery.  
Results: We identified 1,111 stillbirths among a population of 865,429 unique women with 
encounter data available from electronic health records. Among a sample of 127 chart reviewed 
cases, only 35 (27.6%) were confirmed stillbirth cases, 45 (35.4%) possible stillbirth cases, 39 
(30.7%) cases of miscarriage, and 8 (6.3%) cases of live births. Among confirmed stillbirth 
cases, 51.4% had any syphilis testing conducted, 31.4% had testing before their stillbirth 
delivery, 42.9% had testing after the delivery, and only 22.9% had testing before and after 
delivery.  
Conclusions: A majority of women with a stillbirth delivery do not receive syphilis screening 
adherent to CDC guidelines. Stillbirth ICD codes do not accurately identify cases of stillbirth. 
 








A stillbirth is defined as a delivery of fetus born at 20 weeks or greater of gestation with 
no signs of life
1
. Stillbirths have numerous potential causes such as restriction of fetal growth
2-4
, 






. In the United 
States, the rate of stillbirth slowly declined from 6.05 cases per 1,000 births between 2006 and 
2012
10
 to 5.89 per 1,000 births in 2017
11
. Moreover, there are significant disparities in stillbirth 
rates among racial and ethnic minority groups, suggesting more progress is needed to achieve 
equity as well as the U.S. Health People 2020 target of 5.6 per 1,000 births
12
.  
Rates of primary and secondary (P & S) syphilis increased in recent years, with a 72.7% 
increase from 2013 to 2017 (from 5.5 per 100,000 population to 9.5 per 100,000 population) in 
the United States
13
. Despite the increase in P & S syphilis being most prominent among men 
who have sex with men, rates of congenital syphilis have more than doubled during the same 
time period (9.2 per 100,000 live births to 23.3 per 100,000 live births, respectively)
13
.  During 
this time in Indiana, the rate of P & S syphilis doubled, increasing by 60% among females
14
.  
Congenital syphilis rates rose from 0 to 9.5 cases per 100,000
15
.  This rise in congenital syphilis 
rates might indicate a possible increase in syphilitic stillbirth rates during this time period. 
The Centers for Disease Control and Prevention (CDC), U.S. Preventive Services Task 
Force (USPSTF), and the state of Indiana all recommend screening at the time of diagnosis of 
pregnancy and in the third trimester if a woman is considered “high” risk
16
.  The USPSTF and 
CDC also recommend testing at the time of delivery and in the case of stillbirth
17
.  Despite these 
recommendations, several studies
18-21
 have shown gaps in screening at the first prenatal visit and 
failure to rescreen during the third trimester among congenital syphilis cases. Further, a study
22
 







insured patients per year, found that approximately one-third of stillbirth cases did not receive 
syphilis testing either prenatally or after the stillbirth delivery. The study
22
 utilized International 
Classification of Diseases, Ninth Revision, (ICD-9) codes to identify cases of stillbirth. 
However, the use of ICD-9 codes to identify cases of stillbirth has only been validated once in 
the U.S., using patients in California from 1992-1993 and therefore may not currently be valid
23
. 
There is little evidence available regarding provider adherence to the CDC syphilis testing 
guidelines among women with stillbirth. The objective of the study was to utilize electronic 
health records (EHRs) to evaluate prenatal syphilis screening and syphilis testing after delivery, 
among women with a stillbirth delivery. 
 
MATERIALS AND METHODS 
Study Design and Setting 
We employed a retrospective cohort study design using data from the Indiana Network 
for Patient Care (INPC). The INPC is a health information exchange (HIE) network that 
connects and aggregates EHRs for more than 100 hospitals representing 38 health systems
24
. The 
INPC utilizes a master person index to uniquely link medical records for the same individual 
across medical encounters, laboratory test results, and clinical procedures. With respect to the 
state’s population, the INPC represents two-thirds of Indiana residents. The INPC is frequently 
used to study both health services and population health outcomes
25
.  
To assess syphilis testing compliance with CDC guidelines, we compared syphilis 
laboratory testing dates to the date of stillbirth delivery recorded for women who gave birth 
between January 1, 2014 and December 31, 2016. This study was approved by Indiana 







Cohort Assembly and Data Extraction 
Women were included if they were aged 18-44 years old and possessed an ICD-9-CM or 
ICD-10-CM diagnosis of stillbirth delivery documented in the INPC. The ICD-9-CM codes 
utilized to identify stillbirth delivery were V27.1, V27.3, V27.4, V27.6, V27.7, V32.X, V35.X, 
V36.X, 656.4, and 779.9. For ICD-10-CM, codes utilized were Z37.1, Z37.3, Z37.4, Z37.6, 
Z37.7, O36.4, P95, and P96.9. A case of stillbirth delivery was defined based on the presence of 
at least one of the aforementioned diagnostic codes documented in the INPC aggregated medical 
record during the study period. The date of the first diagnosis with stillbirth was defined as the 
date of stillbirth. If a patient received multiple stillbirth diagnostic codes ≥20 weeks apart within 
the study period, that next diagnosis was considered a new case of stillbirth.  
Cases of stillbirth were separated into three categories based on the presence of syphilis 
testing and syphilis test results documented in the INPC during the time interval of 300 days 
before and 30 days after the date of stillbirth. The categories included cases in which 1) the 
woman had any positive or reactive syphilis laboratory test; 2) the woman had all syphilis 
laboratory tests that were negative, non-reactive, or indeterminate; and 3) the woman had no 
evidence of syphilis laboratory testing. All patient data, including medical record numbers, 
prenatal encounters (ICD-9-CM: V22.X, V23.X, V28.9, and V72.42; ICD-10-CM: Z34.X, 
Z36.X, Z3A.X and O09.X), names of institutions that documented the stillbirth delivery, 
encounter settings, and laboratory test results, during the time interval of 300 days before and 30 
days after the date of stillbirth were linked and extracted for each case from the INPC. 
Chart Reviews 
Data quality checks were performed using medical chart reviews among a sample of 







clinician notes up to 35 days after diagnosis; 2) the syphilis laboratory testing and treatment 
information might be missing from designated fields in the structured medical record but might 
be present in clinician notes; or 3) the stillbirth was potentially caused by other underlying 
conditions which may have been documented in clinician notes, ultrasound results, genetic 
screening results, placental examinations, and fetal autopsies. A confirmed case of stillbirth was 
defined as that in which a fetus had no sign of life at the time of delivery and gestational age was 
20 weeks or later. A possible case of stillbirth was defined as a case with 1) no sign of life and 
missing gestational age; or 2) missing information on signs of life at the time of delivery and 
missing gestational age. A false case of stillbirth was defined as a case in which the fetus was 
documented to be born alive or gestational age was <20 weeks, which should have been 
classified as a miscarriage
1
. 
The sample for medical chart reviews was stratified by category. All positive or reactive 
syphilis cases were reviewed to verify the clinical diagnosis. For the other two categories, we 
randomly sampled roughly 10% of remaining cases for data quality purposes to confirm the 
stillbirth diagnosis and the syphilis laboratory testing result of negative, non-reactive, 
indeterminate, or lack thereof. Sample size was determined based on our goal of performing a 
data quality check; generally, a 10% sample of cases is sufficient to identify quality issues. A 
trained medical chart reviewer (K.A.) conducted all chart reviews. No additional syphilis 
laboratory testing or treatment information were found in the detailed medical charts, suggesting 
the dataset contained all of the available information from the INPC. Additionally, no other 









Assessment of Provider Adherence 
In order to assess provider adherence to guidelines, we examined whether and the number 
of times a woman was tested for syphilis during the pregnancy and after the stillbirth delivery for 
each case. Laboratory tests were included up to 300 days before and 30 days after the date of 
stillbirth to allow for potential delays in clinical documentation. A case was determined to have 
received prenatal testing of syphilis if testing occurred within 1 to 300 days before the stillbirth 
diagnosis. A case was determined to have received post-delivery testing of syphilis if testing 
occurred on the same day of the stillbirth diagnosis or up to 30 days after the date of stillbirth. 
For a confirmed or possible stillbirth case to be considered adherent to guidelines, the case had to 
possess both prenatal testing and post-delivery testing of syphilis. Among positive syphilis cases, 
we did not require cases to have the presence of syphilis testing among the 1
st
 trimester and 3
rd
 
trimester due to the possibility of the stillbirth delivery occurring before the 3
rd
 trimester, and 
some cases did not document the gestational age of fetus at the time of delivery. 
Statistical Analyses 
Prevalence of provider adherence to guidelines was estimated and stratified by stillbirth 
case status. We further examined adherence based on whether the medical record contained 
documentation of prenatal visits. All analyses were conducted using SAS version 9.4 (SAS 
Institute Inc., Cary, NC, USA). 
RESULTS 
Overall Cohort Description and Category Classifications 
Over the 2-year study period, a total of 865,429 unique women, between the ages of 18 
and 44 years old, had at least one encounter in the INPC. Of these, 1,111 (0.1%) women received 







When categorized, there were 2 (0.2%) syphilis positive stillbirth cases, 527 (47.4%) 
stillbirth cases in which syphilis laboratory testing occurred with a negative/indeterminate result, 
and 582 (52.4%) stillbirth cases that possessed no documentation of syphilis laboratory testing. 
A total 127 chart reviews from 18 different institutions were conducted: 2 syphilis positive cases; 
53 (10.1%) cases with a negative/indeterminate laboratory result; and 72 (12.4%) cases with no 
syphilis laboratory testing. 
Assessment of ICD-based Stillbirth Diagnosis 
No cases with multiple deliveries were found from chart review. The 2 syphilis positive 
cases had reactive nontreponemal, rapid plasma regain (RPR) testing, but no confirmatory 
treponemal test was conducted.  
Chart reviews of 127 cases revealed only 35 (27.6%) confirmed stillbirth cases, 45 
(35.4%) possible stillbirth cases, 39 (30.7%) cases of miscarriage, and 8 (6.3%) cases with live 
births (Table 1). Of the possible stillbirth cases, 13.3% (6/45) had missing information on signs 
of life at time of delivery and 86.7% (39/45) had missing information on both gestational age and 
signs of life. Demographic information for the total cases and those charts reviewed are provided 
in Table 1. Among the miscarriage cases, gestational age ranged from 6 weeks to 19 weeks plus 
6 days and the average length of gestation was 12.6 weeks.  
Assessment of Provider Adherence 
Only 22.9% (8/35) of confirmed stillbirth cases and 2.2% (1/45) possible stillbirth cases 
had both prenatal syphilis testing and post-delivery syphilis testing to adhere to guidelines. When 
looking at the entire cohort, only 10.7% (119/1111) cases had both prenatal syphilis testing and 
post-delivery syphilis testing. Syphilis testing in general was low as only 37.8% (48/127) among 







before or after delivery. When only assessing if cases were tested after stillbirth, 42.9% (15/35) 
confirmed stillbirth cases, 8.9% (4/45) possible stillbirth cases, and 29.8% (331/1111) among the 
total cohort were tested for syphilis after the stillbirth diagnosis. Of the two cases which tested 
positive for syphilis during the pregnancy period, neither case was tested for syphilis at the time 
of or following the stillbirth diagnosis. Assessment of syphilis testing after the stillbirth delivery 
found no positive syphilis laboratory test results for any cases. However, one case was found to 
be treated for syphilis (identified in provider notes) following a confirmed stillbirth. The case 
had no syphilis laboratory testing before or after the stillbirth delivery. Syphilis testing 
information is presented in Table 3. 
 
Assessment of Prenatal Visits 
In the subset of chart reviewed cases, assessment of prenatal visits found that 100% (2/2) 
of syphilis positive cases, 66.0% (35/53) of cases which received syphilis testing, and 29.2% 
(21/72) of cases with no syphilis testing had at least one prenatal visit. When stratified by 
stillbirth case status, 48.6% (17/35) of confirmed stillbirth cases, 35.6% (16/45) of possible 
stillbirth cases, 75% (6/8) of live birth cases, and 48.7% (19/39) of miscarriage cases had at least 
one prenatal visit. Of the 58 cases with a prenatal visit, 37 (63.8%) cases were tested for syphilis 
before the date of stillbirth. 
 
DISCUSSION 
Using a population-based cohort, we examined provider adherence to CDC 
recommended laboratory testing guidelines for stillbirth deliveries. First, we discovered that ICD 







of stillbirth delivery are compliant with laboratory testing recommendations. Without compliant 
syphilis screening, congenital syphilis cases, including syphilitic stillbirths, are unlikely to be 
identified and reported to the national STD surveillance system. The study provides both 
methodological guidance for secondary analysis of administrative health data and identifies 
further areas for study as well as intervention to improve syphilis screening in stillbirth delivery 
cases. 
Due to the rate of confirmed stillbirth cases observed in this study for ICD-based stillbirth 
delivery codes, we do not recommend the use of ICD codes alone to identify cases of stillbirth 
delivery for secondary analyses. To better identify stillbirth cases, our study suggests that 
gestational ages and additional information about status of delivery are needed to confirm case 
status. Unfortunately, many cases identified as possible stillbirth cases lacked sufficient 
structured data in the patient’s medical record to confirm case status. Although documentation of 
delivery details does exist in free-text clinical notes from obstetrics and gynecology (OB/GYN) 
providers, such data may not be readily available in HIE networks for use by quality 
improvement, public health, or research teams. While the INPC receives laboratory test results 
ordered by OBGYN providers, not all EHR systems used in OB/GYN clinics submit medical 
records to the HIE data network.  
Another key finding is that the majority of women with a stillbirth delivery do not receive 
syphilis testing adherent to CDC guidelines as only 22.9% (8/35) of confirmed stillbirth cases 
and 2.2% (1/45) possible stillbirth cases were found to be adherent. Our results indicate provider 
knowledge of guidelines may be low based on the number of confirmed stillbirth cases, 42.9% 
(15/35), which were tested for syphilis following a stillbirth delivery. Results also show that 







any time during their pregnancy or after a stillbirth or miscarriage, as only 37.8% of chart 
reviewed cases and 47.6% of the total stillbirth population had any syphilis testing. These 
findings suggest that more public health interventions are required to ensure that all pregnant 
women are screened for syphilis and that additional provider education may be required to 
ensure syphilis screening occurs after a stillbirth delivery. Finally, these findings may have 
implications for public health surveillance and indicate that cases of congenital syphilis may be 
underdiagnosed and underreported. 
Based on the assessment of prenatal visits, if a patient had a prenatal visit, they tended to 
be tested for syphilis during their pregnancy. However, 54.3% of cases had no prenatal visits, 
suggesting further public health interventions are needed to ensure pregnant women in Indiana 
receive prenatal care. This result is significant as one case, without prenatal syphilis testing, was 
found to be treated for syphilis immediately following a confirmed stillbirth. However, no 
autopsy was performed on the fetus and placental examination results were missing from the 
patient record to determine if syphilis was a cause of fetal demise. Lack of documentation 
hinders after-action mortality review by public health professionals in coordination with health 
system providers. 
This study has several limitations. The INPC may not capture all prenatal visits as the 
HITECH Act
26
 did not require specialty care, such as OB/GYN clinics, to participate in health 
information exchange. Because of this, patient visit data may only be available within a specialty 
EHR system. Thus, cases might have had prenatal visits, but the visit information, including 
gestational age, last menstrual period, expected date of delivery, and potential causes of stillbirth, 
was not present in the INPC. Therefore, we could not assess when prenatal care began during a 







clinics, should be captured in the INPC as laboratory results are sent to the INPC directly from 
public, hospital, and commercial laboratories. An additional limitation was that we may have 
included syphilis testing not associated with a pregnancy as we included all syphilis testing up to 
300 days before a stillbirth diagnosis. We chose this cutoff because we believed that the 
conception date could not accurately be determined, and a more restrictive cutoff may exclude 
some prenatal syphilis testing.  Our results may therefore overstate syphilis testing during 
pregnancy. Another limitation was that the low rate of syphilis testing following delivery may 
have been due to providers forgoing testing because the cause of the stillbirth was known prior to 
delivery. However, this theory could not be confirmed despite our chart review. Additionally, the 
rates of provider adherence and misclassification of stillbirth may have differed between 
providers, facilities, or health systems. However, we could not assess these differences due to 
data agreements between the INPC and health systems which prohibit these comparisons. 
Finally, the findings of this study may not be generalizable outside of the state of Indiana, 
however patients were from multiple health systems of various sizes. 
In conclusion, ICD codes for stillbirth should be utilized cautiously when identifying case 
of stillbirth in administrative data, and provider adherence to CDC guidelines for syphilis testing 
is low. The results in this study may provide helpful information for public health’s efforts in 
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Table 1. Demographic information stratified by case status. 





















            
<20 5 4 0 3 12 92 8.28 
20-34 24 32 8 22 86 844 75.97 
35-39 0 5 0 9 14 131 11.79 
40+ 6 4 0 5 15 44 3.96 
Maternal 
race/ethnicity 
       
White (Non-
Hispanic) 
26 22 5 26 79 663 59.68 
Black (Non-
Hispanic) 
5 3 1 6 15 121 10.89 
Hispanic or 
Latino 




0 0 1 0 1 3 0.27 
Asian 0 0 0 0 0 1 0.09 
Other 3 5 1 4 13 110 9.90 




       
Emergency 
Department 
2 7 0 17 26 131 11.79 
Inpatient 23 8 4 14 49 65 5.85 
Obstetrics 0 2 0 2 4 1 0.09 
Outpatient 3 6 3 5 17 237 21.33 
Unknown 7 22 1 1 31 677 60.94 
Location of ICD diagnosing setting was determined by the location in which the stillbirth ICD 







Table 2. Chart reviewed stillbirth case status stratified by category. 









0 1 0 1 2 
Received Syphilis 
Laboratory Testing 
with Negative or 
Indeterminate Result 
21 10 4 18 53 
No Syphilis 
Laboratory Testing  14 34 4 20 72 
Total Case Statuses 
35 45 8 39 127 
Cases represent a pregnancy episode which possessed at least one stillbirth diagnostic code 

















Table 3. Syphilis testing adherence stratified by case group and case status 




Testing Before and 
After Delivery** 






















8 37 17.8% 5 40 11.1% 4 41 8.9% 1 44 2.2% 
Live Birth 
(n=8) 
4 4 50.0% 4 4 50.0% 2 6 25.0% 2 6 25.0% 
Miscarriage 
(n=39) 
18 21 46.2% 17 22 43.6% 8 31 20.5% 8 31 20.5% 




529 582 47.6% 317 794 28.5% 331 780 29.8% 119 992 10.7% 
*Any testing was defined as any testing within 300 days before or 30 days after delivery.  
**Testing after delivery was defined as syphilis testing on the same day or 30 days after the stillbirth diagnosis.  
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